FDA Marketing Exclusivity Periods Limited To Same Active Moiety
By EsqSocial Corporation 12/09/17
In Otsuka Pharm. Co., Ltd. v. Price, No. 16-5229 (D.C. Cir. Aug. 29, 2017), the U.S. Court of Appeals for the District of Columbia Circuit affirmed the district court decision upholding FDA’s “same moiety” test for defining the zone of FDA market...
By: Foley & Lardner LLP